ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,805 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselNBE-Therapeutics AG
NBE-Therapeutics AG Logo
Verified· 3 sources

NBE-Therapeutics AG

Summary

About the company

The core activity of NBE-Therapeutics AG is the development and research of therapeutics, particularly in the field of cancer treatment. The company focuses on the development of antibody-drug conjugates (ADCs) and other therapeutics targeting the fight against cancer cells.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Industry:Research & DevelopmentPharmaceutical Industry
✓ Offered7
Oncology treatments
Oncology treatments based on next-generation antibody-drug conjugates, developed to target solid tumors and improve survival and quality of life for cancer patients.
Antibody-drug conjugate technology
Antibody-drug conjugate platform combining monoclonal antibodies with small-molecule payloads, including tailored design of antibody, payload, DAR, conjugation site and homogeneity.
Site-specific conjugation
Enzymatic site-specific antibody conjugation with sortaseA transpeptidase, described as SMAC technology for antibody conjugation.
PNU anthracycline payload
Anthracycline-based payload for ADCs, described as a highly potent DNA-damaging intercalating toxin with picomolar potency.
Antibody discovery
Discovery of novel binders against new targets using a mammalian antibody library display system.
Press

Media

October 5, 2020Media
Startups win strong and well-connected board members
startupticker.ch
October 29, 2019Media
Biotech startups strengthen their teams
startupticker.ch

Knowledge

No knowledge articles yet

Once NBE-Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NBE-Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NBE-Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NBE-Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60i
4057 Basel

At a glance

Legal form
Corporation
UID
CHE-153.827.725
Founded
2012 · 14 years
Last commercial register change
July 10, 2026
Employees
21 to 50

Similar companies

SA
SpiroChem AG
Basel
SA
Scailyte AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel